BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1796 related articles for article (PubMed ID: 19762075)

  • 1. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.
    Peek GJ; Mugford M; Tiruvoipati R; Wilson A; Allen E; Thalanany MM; Hibbert CL; Truesdale A; Clemens F; Cooper N; Firmin RK; Elbourne D;
    Lancet; 2009 Oct; 374(9698):1351-63. PubMed ID: 19762075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR).
    Peek GJ; Elbourne D; Mugford M; Tiruvoipati R; Wilson A; Allen E; Clemens F; Firmin R; Hardy P; Hibbert C; Jones N; Killer H; Thalanany M; Truesdale A
    Health Technol Assess; 2010 Jul; 14(35):1-46. PubMed ID: 20642916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR).
    Thalanany MM; Mugford M; Hibbert C; Cooper NJ; Truesdale A; Robinson S; Tiruvoipati R; Elbourne DR; Peek GJ; Clemens F; Hardy P; Wilson A;
    BMC Health Serv Res; 2008 Apr; 8():94. PubMed ID: 18447931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure.
    Peek GJ; Clemens F; Elbourne D; Firmin R; Hardy P; Hibbert C; Killer H; Mugford M; Thalanany M; Tiruvoipati R; Truesdale A; Wilson A
    BMC Health Serv Res; 2006 Dec; 6():163. PubMed ID: 17187683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group.
    Lancet; 1996 Jul; 348(9020):75-82. PubMed ID: 8676720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.
    Mugford M; Elbourne D; Field D
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001340. PubMed ID: 18646070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.
    Elbourne D; Field D; Mugford M
    Cochrane Database Syst Rev; 2002; (1):CD001340. PubMed ID: 11869599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age.
    Pediatrics; 1998 Apr; 101(4):E1. PubMed ID: 9521968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The experience of extracorporeal membrane oxygenation for severe acute respiratory failure in adults].
    Sun B; Wang CT; Wu J; Li XY; He HY; Zhang CY; Tong ZH; Zhan QY; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Nov; 35(11):804-8. PubMed ID: 23290033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. The Extracorporeal Membrane Oxygenation Economics Working Group.
    Roberts TE
    BMJ; 1998 Oct; 317(7163):911-5; discussion 915-6. PubMed ID: 9756807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial.
    Petrou S; Bischof M; Bennett C; Elbourne D; Field D; McNally H
    Pediatrics; 2006 May; 117(5):1640-9. PubMed ID: 16651318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of the NHS England National Extracorporeal Membrane Oxygenation Service for adults with respiratory failure: a multicentre observational cohort study.
    Warren A; Chiu YD; Villar SS; Fowles JA; Symes N; Barker J; Camporota L; Harvey C; Ledot S; Scott I; Vuylsteke A;
    Br J Anaesth; 2020 Sep; 125(3):259-266. PubMed ID: 32736826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal membrane oxygenation for adult respiratory failure.
    Peek GJ; Moore HM; Moore N; Sosnowski AW; Firmin RK
    Chest; 1997 Sep; 112(3):759-64. PubMed ID: 9315812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
    Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
    Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of patients receiving prolonged extracorporeal membrane oxygenation for respiratory support.
    Na SJ; Jung JS; Hong SB; Cho WH; Lee SM; Cho YJ; Park S; Koo SM; Park SY; Chang Y; Kang BJ; Kim JH; Oh JY; Park SH; Yoo JW; Sim YS; Jeon K
    Ther Adv Respir Dis; 2019; 13():1753466619848941. PubMed ID: 31090503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial.
    Petrou S; Edwards L;
    Arch Dis Child Fetal Neonatal Ed; 2004 May; 89(3):F263-8. PubMed ID: 15102733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study).
    Jacquot A; Lepage X; Merckle L; Girerd N; Levy B
    BMJ Open; 2019 Oct; 9(10):e031697. PubMed ID: 31615800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Extracorporeal Life Support Organization.
    Green TP; Moler FW; Goodman DM
    Crit Care Med; 1995 Jun; 23(6):1132-9. PubMed ID: 7774227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Propensity Matched Outcomes in Severe COVID-19 Respiratory Failure-Extracorporeal Membrane Oxygenation or Maximum Ventilation Alone.
    Mustafa AK; Joshi DJ; Alexander PJ; Tabachnick DR; Cross CA; Jweied EE; Mody NS; Huh MH; Fasih S; Pappas PS; Tatooles AJ
    Ann Surg; 2021 Nov; 274(5):e388-e394. PubMed ID: 34617934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study.
    Hodgson CL; Higgins AM; Bailey MJ; Anderson S; Bernard S; Fulcher BJ; Koe D; Linke NJ; Board JV; Brodie D; Buhr H; Burrell AJC; Cooper DJ; Fan E; Fraser JF; Gattas DJ; Hopper IK; Huckson S; Litton E; McGuinness SP; Nair P; Orford N; Parke RL; Pellegrino VA; Pilcher DV; Sheldrake J; Reddi BAJ; Stub D; Trapani TV; Udy AA; Serpa Neto A;
    Lancet Respir Med; 2022 Nov; 10(11):1038-1048. PubMed ID: 36174613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.